New Data Is Likely To Add Fuel To The Drug-Eluting-Stent Debate
This article was originally published in The Gray Sheet
Executive Summary
New trial data presented at the American College of Cardiology annual meeting could be another obstacle to drug-eluting-stent manufacturers' efforts to reverse a year-long sales slump